The results suggest that treatment with Ts-AES systemically or in situ inhibits pro-inflammatory cytokine expression (TNF-α and IL-6) but stimulates the expression of regulatory cytokines (mainly IL-10) after MI has occurred, which is consistent with reduced pathological damage of infarcted heart tissue and improved heart tissue healing. This evidence concerns the gene IL10 and myocardial infarction.